AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/10.31579/2688-7517/183
1 State Medical University, Rostov-on-Don
2 Medical Center “Hippocrates”, Rostov-on-Don
3 Regional Medical Center, Rostov-on-Don, Russian Federation
*Corresponding Author: B. Zaydiner Regional Medical Center, Rostov-on-Don, Russian Federation.
Citation: Mihai-Darius Cernescu, Monica Butnariu, (2024), About Delirium in Cancer Patients, J. Pharmaceutics and Pharmacology Research, 7(9); DOI:10.31579/2688-7517/183
Copyright: © 2024, B. Zaydiner. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 19 March 2024 | Accepted: 18 April 2024 | Published: 19 August 2024
Keywords: cosmetic product; dermo cosmetics; skin care; active substances
The number of cancer survivors grows, the scope of care broads from treating the disease alone to managing cancer-related symptoms, including comorbid mental health disorders. Many cancer patients have delirium, this is often fatal problem. The review presents the data about epidemiology, risk factors, pathogenesis, clinical-diagnostic and treatment aspects.
According to latest estimates of the global cancer burden, in 2022 there were 20 million new cancer cases. As a result of the demographic development, their prevalence is expected to double during the next 10 years. Cancer is a leading cause of death. It accounted for nearly ten million deaths worldwide (around 15% of all deaths) in 2020 (72.5% more than in 1990). For patients, caregivers, and families, going through cancer can be a devastating experience with many stresses and emotional upheavals. Because cancer is potentially life-threatening, the psychological impact of its diagnosis on patients has been an important aspect of clinical oncology.
Meanwhile the number of survivors continues to grow, not just because of earlier detection and treatment, but also because of revolutionary new therapies. This changes the landscape from a terminal illness to more of a chronic illness with periods of remission and exacerbation of symptoms. This perspective on neoplasms has broadened the scope of care from treating the disease alone to managing cancer-related symptoms at different stages of the disease trajectory including mental disorders.
On psychiatric consultation of 546 cancer patients there was revealed that 54% of the referrals were diagnosed as having adjustment disorders, 15
Improving the quality of care requires recognition and addressing patients’ distress, mental disorders and supportive care needs during treatment and after care. Thus, psychosocial and psycho-oncological support services considerably contribute to improving the quality of life of patients as a central outcome criterion of oncological care. It is clear that a more personalized approach to supporting the psychological health of people with cancer is needed. Some people may not want or require support or treatment, others will be able to self-manage, and some may have more complex needs that require more intensive follow-up and support. At diagnosis, the psychological health of patients should be considered alongside their physical health and sources of support offered. Needs and symptoms may also change over time. Being mentally aware is a preference reiterated by seriously ill patients.